{"id":21109,"date":"2025-07-07T17:21:00","date_gmt":"2025-07-07T11:51:00","guid":{"rendered":"https:\/\/niir.org\/blog\/?p=21109"},"modified":"2026-05-15T12:11:42","modified_gmt":"2026-05-15T06:41:42","slug":"top-10-pharmaceutical-intermediates","status":"publish","type":"post","link":"https:\/\/www.niir.org\/blog\/top-10-pharmaceutical-intermediates\/","title":{"rendered":"Top 10 Pharmaceutical Intermediates with High Export Potential for MSMEs"},"content":{"rendered":"\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_87_1 counter-hierarchy ez-toc-counter ez-toc-white ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title\" style=\"cursor:inherit\">Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/www.niir.org\/blog\/top-10-pharmaceutical-intermediates\/#A_Sunrise_Opportunity_for_MSMEs_in_Pharmaceutical_Intermediates_Manufacturing\" >A Sunrise Opportunity for MSMEs in Pharmaceutical Intermediates Manufacturing<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/www.niir.org\/blog\/top-10-pharmaceutical-intermediates\/#Related_Top_Innovations_in_Pharmaceutical_Manufacturing_Technologies\" >Related: Top Innovations in Pharmaceutical Manufacturing Technologies<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/www.niir.org\/blog\/top-10-pharmaceutical-intermediates\/#1_p-Aminophenol_%E2%80%93_The_Backbone_of_Paracetamol_Manufacturing\" >1. p-Aminophenol \u2013 The Backbone of Paracetamol Manufacturing<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/www.niir.org\/blog\/top-10-pharmaceutical-intermediates\/#2_Isatoic_Anhydride_%E2%80%93_Essential_for_Anti-Infectives_and_Antispasmodics_Patients\" >2. Isatoic Anhydride \u2013 Essential for Anti-Infectives and Antispasmodics Patients<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/www.niir.org\/blog\/top-10-pharmaceutical-intermediates\/#3_4-Aminophenol-3-sulfonic_Acid_%E2%80%93_Multipurpose_Anti-Infective_Ingredient\" >3. 4-Aminophenol-3-sulfonic Acid \u2013 Multipurpose Anti-Infective Ingredient<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/www.niir.org\/blog\/top-10-pharmaceutical-intermediates\/#4_35-Dinitrosalicylic_Acid_%E2%80%93_Diagnostic_Applications_for_Biotech_and_Labs\" >4. 3,5-Dinitrosalicylic Acid \u2013 Diagnostic Applications for Biotech and Labs<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/www.niir.org\/blog\/top-10-pharmaceutical-intermediates\/#5_Phenacetin_Intermediate_%E2%80%93_A_Rediscovered_Precursor_for_Steroidal_APIs\" >5. Phenacetin Intermediate \u2013 A Rediscovered Precursor for Steroidal APIs<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/www.niir.org\/blog\/top-10-pharmaceutical-intermediates\/#Related_Empowering_Indias_Growth_Through_Pharmaceutical_Intermediates_API_Production\" >Related: Empowering India\u2019s Growth Through Pharmaceutical Intermediates &amp; API Production<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/www.niir.org\/blog\/top-10-pharmaceutical-intermediates\/#6_Cyclohexanone_%E2%80%93_Solvent_and_Precursor_for_Adipic_Acid_and_APIs\" >6. Cyclohexanone \u2013 Solvent and Precursor for Adipic Acid and APIs<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/www.niir.org\/blog\/top-10-pharmaceutical-intermediates\/#7_Phthalic_Anhydride_%E2%80%93_A_Key_Link_in_the_Painkiller_and_Resin_Chains\" >7. Phthalic Anhydride \u2013 A Key Link in the Painkiller and Resin Chains<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/www.niir.org\/blog\/top-10-pharmaceutical-intermediates\/#8_24-Dichlorophenoxyacetic_Acid_24-D_%E2%80%93_Agrochemical_Meets_Pharma\" >8. 2,4-Dichlorophenoxyacetic Acid (2,4-D) \u2013 Agrochemical Meets Pharma<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/www.niir.org\/blog\/top-10-pharmaceutical-intermediates\/#9_Adipic_Acid_%E2%80%93_From_Neurology_to_Nylon\" >9. Adipic Acid \u2013 From Neurology to Nylon<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/www.niir.org\/blog\/top-10-pharmaceutical-intermediates\/#10_Benzoyl_Peroxide_%E2%80%93_A_Safe_Bet_in_Dermatological_APIs\" >10. Benzoyl Peroxide \u2013 A Safe Bet in Dermatological APIs<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/www.niir.org\/blog\/top-10-pharmaceutical-intermediates\/#What_Are_the_Considerations_for_MSMEs_Manufacturing\" >What Are the Considerations for MSMEs Manufacturing?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/www.niir.org\/blog\/top-10-pharmaceutical-intermediates\/#Reasons_Why_Pharmaceutical_Intermediates_Are_Best_for_MSMEs\" >Reasons Why Pharmaceutical Intermediates Are Best for MSMEs<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/www.niir.org\/blog\/top-10-pharmaceutical-intermediates\/#For_more_information_check_our_Project_Reports\" >For more information check our Project Reports<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/www.niir.org\/blog\/top-10-pharmaceutical-intermediates\/#How_NPCS_Assists_With_Your_Pharma_Intermediate_Manufacturing_Needs\" >How NPCS Assists With Your Pharma Intermediate Manufacturing Needs<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/www.niir.org\/blog\/top-10-pharmaceutical-intermediates\/#Conclusion_A_Local_Edge_in_a_Global_Market\" >Conclusion: A Local Edge in a Global Market<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/www.niir.org\/blog\/top-10-pharmaceutical-intermediates\/#Which_business_to_start_How_to_choose_a_business_idea\" >Which business to start? How to choose a business idea?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2 id=\"a-sunrise-opportunity-for-msmes-in-pharmaceutical-intermediates-manufacturing\" class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"A_Sunrise_Opportunity_for_MSMEs_in_Pharmaceutical_Intermediates_Manufacturing\"><\/span>A Sunrise Opportunity for MSMEs in Pharmaceutical Intermediates Manufacturing<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">India is known internationally for its generic drug production. For micro, small, and medium enterprises (MSMEs), there is a huge potential for exporting and manufacturing Pharmaceutical intermediates, while large pharmaceutical companies continue to control API exports. Intermediates are in high demand and and with the current geopolitical tensions focusing on diversifying supply chains, India makes for a perfect hire due to its low operational costs, skilled workers, and developed chemical industry.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Unlike the other domains, pharmaceutical intermediates have lower regulation, require lower capital as well as investment and have a steady demand globally making it ideal for MSMEs, startups and entrepreneurs. This article provides insights about the high demand intermediates, their market demand trends, production details, and the role of MSMEs in harnessing this potential.<\/p>\n\n\n\n<h3 id=\"related-top-innovations-in-pharmaceutical-manufacturing-technologies\" class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Related_Top_Innovations_in_Pharmaceutical_Manufacturing_Technologies\"><\/span>Related: <a href=\"https:\/\/niir.org\/blog\/top-innovations-in-pharmaceutical-manufacturing-technologies\/\">Top Innovations in Pharmaceutical Manufacturing Technologies<\/a><span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<h2 id=\"1-paminophenol-the-backbone-of-paracetamol-manufacturing\" class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"1_p-Aminophenol_%E2%80%93_The_Backbone_of_Paracetamol_Manufacturing\"><\/span><strong>1. p-Aminophenol \u2013 The Backbone of Paracetamol Manufacturing<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">p-Aminophenol belongs to one of the most important pharmaceutical intermediates in the world. There is a global market for paracetamol and, therefore for p-aminophenol as well.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The process usually starts with the production of nitrophenol by the nitration of phenol, which is further p-aminophenol by catalytic hydrogenation. The reaction takes place with metal catalysts at fixed temperature and pressure conditions. There is demand in Europe and Latin America and even in some parts of Southeast Asia where formulation units seek dependable outsourcing to reduce costs without sacrificing quality.<\/p>\n\n\n\n<h2 id=\"2-isatoic-anhydride-essential-for-antiinfectives-and-antispasmodics-patients\" class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"2_Isatoic_Anhydride_%E2%80%93_Essential_for_Anti-Infectives_and_Antispasmodics_Patients\"><\/span><strong>2. Isatoic Anhydride \u2013 Essential for Anti-Infectives and Antispasmodics Patients<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">This intermediate is highly relevant in the production of derivatives of anthranilic acid which are used as the backbone of various drugs in anti-inflammation and anti-infection medicine. We can observe that Indian chemical companies have specialized in the production of this intermediate, positioning them well for scale-up by MSMEs.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Isatoic anhydride is usually synthesized from anthranilic acid and phosgene or triphosgene, followed by a recrystallization step. New green synthesis methods and encapsulated reactors are more eco-friendly, although the older methods were quite toxic. MSMEs focusing on benzimidazole derivatives or NSAIDs can produce this intermediate in bulk for export.<\/p>\n\n\n\n<h2 id=\"3-4aminophenol3sulfonic-acid-multipurpose-antiinfective-ingredient\" class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"3_4-Aminophenol-3-sulfonic_Acid_%E2%80%93_Multipurpose_Anti-Infective_Ingredient\"><\/span><strong>3. 4-Aminophenol-3-sulfonic Acid \u2013 Multipurpose Anti-Infective Ingredient<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">4-Aminophenol-3-sulfonic acid remained a dye intermediate for years, but it is now finding more use in disinfectants and antiseptic formulations in pharmaceuticals. The multifunctional nature of the compound makes it very appealing to manufacturers and traders as an anti-infective agent for diverse industries.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">P-aminophenol\u2019s sulfonation reaction yields this compound. For reproducibility, pH control during sulfonation, sulfonation temperature, and crystallization time must be controlled. <\/p>\n\n\n\n<h2 id=\"4-35dinitrosalicylic-acid-diagnostic-applications-for-biotech-and-labs\" class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"4_35-Dinitrosalicylic_Acid_%E2%80%93_Diagnostic_Applications_for_Biotech_and_Labs\"><\/span><strong>4. 3,5-Dinitrosalicylic Acid \u2013 Diagnostic Applications for Biotech and Labs<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">3,5-Dinitrosalicylic acid is used extensively in the creation of colorimetric enzyme assays and diagnostics, particularly in diabetes detection. Dinitrosalicylic acid is commercially available in countries with developing medical research systems.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The manufacturing process requires the nitration of salicylic acid within a controlled acidic environment. The reaction is exothermic and thus requires cooling systems alongside safety infrastructure. There seems to be strong demand for this molecule among MSMEs serving diagnostic kit manufacturers and biotech exporters.<\/p>\n\n\n\n<h2 id=\"5-phenacetin-intermediate-a-rediscovered-precursor-for-steroidal-apis\" class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"5_Phenacetin_Intermediate_%E2%80%93_A_Rediscovered_Precursor_for_Steroidal_APIs\"><\/span><strong>5. Phenacetin Intermediate \u2013 A Rediscovered Precursor for Steroidal APIs<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">This intermediary is still procured in some Latin American and Eastern European regions due to their older formulation pipelines.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">With the use of p-aminophenol, the process starts with its acetylation in a solvent medium with an acidic catalyst. The solid obtained undergoes filtration, washing, and drying. Exporters with connections to legacy pharma producers or grey-market formulators have steady demand opportunities in this niche.<\/p>\n\n\n\n<h3 id=\"related-empowering-indias-growth-through-pharmaceutical-intermediates-amp-api-production\" class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Related_Empowering_Indias_Growth_Through_Pharmaceutical_Intermediates_API_Production\"><\/span>Related: <a href=\"https:\/\/www.entrepreneurindia.co\/blogs\/pharmaceutical-intermediates\/\">Empowering India\u2019s Growth Through Pharmaceutical Intermediates &amp; API Production<\/a><span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<h2 id=\"6-cyclohexanone-solvent-and-precursor-for-adipic-acid-and-apis\" class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"6_Cyclohexanone_%E2%80%93_Solvent_and_Precursor_for_Adipic_Acid_and_APIs\"><\/span><strong>6. Cyclohexanone \u2013 Solvent and Precursor for Adipic Acid and APIs<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Used in both the pharmaceutical and polymer industries, Cyclohexanone is a well-established chemical intermediate. Adipic acid, which further leads to nylon production, and some tranquilizers and sedatives, uses cyclohexanone as a vital component.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The method for obtaining it includes air oxidation of cyclohexane or dehydrogenation of cyclohexanol, followed by distillation. MSMEs with dual markets (pharma and textile) can capitalize on this solvent that is frequently imported, maximizing profit with its dual-market applications.<\/p>\n\n\n\n<h2 id=\"7-phthalic-anhydride-a-key-link-in-the-painkiller-and-resin-chains\" class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"7_Phthalic_Anhydride_%E2%80%93_A_Key_Link_in_the_Painkiller_and_Resin_Chains\"><\/span><strong>7. Phthalic Anhydride \u2013 A Key Link in the Painkiller and Resin Chains<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Phthalic anhydride is a key feedstock for some non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen and naproxen and also strengthens the expanding markets of polyester resins and plasticizers.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">This compound is made through the oxidation of o-xylene in vapor-phase reactors with vanadium pentoxide catalysts. This is a well-established process, and the product has both industrial and medical-grade markets. India is often a supplier of these regions due to competitive rates, especially Europe, North Africa, and Central Asia.<\/p>\n\n\n\n<h2 id=\"8-24dichlorophenoxyacetic-acid-24d-agrochemical-meets-pharma\" class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"8_24-Dichlorophenoxyacetic_Acid_24-D_%E2%80%93_Agrochemical_Meets_Pharma\"><\/span><strong>8. 2,4-Dichlorophenoxyacetic Acid (2,4-D) \u2013 Agrochemical Meets Pharma<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">2,4-D is an herbicide but also serves as an intermediate for therapeutic drugs used in autoimmune and inflammatory diseases, especially those still in clinical trials. As some biotech companies look into diverse applications of the product, its utilization in pharma is expected to grow.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Manufacture consists of the phenoxyacetic acid chlorination with chlorine-containing reagents in alkaline medium. Agro-pharma crossovers keep demand steady, allowing exporters to diversify their client base.<\/p>\n\n\n\n<h2 id=\"9-adipic-acid-from-neurology-to-nylon\" class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"9_Adipic_Acid_%E2%80%93_From_Neurology_to_Nylon\"><\/span><strong>9. Adipic Acid \u2013 From Neurology to Nylon<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Analytical labs produced gabapentin, a primary medication for treating a wide range of neurological disorders by using multistep synthesis techniques. One of the key raw materials, adipic acid, is in high demand not only in the pharmaceutical sector but also in polyamide and synthetic textile industries.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The typical pathway involves the oxidation of cyclohexanol and cyclohexanone with nitric acid. Then the product is purified. Due to post-pandemic anxiety and neurological therapy necessitating gabapentin prescription, the raw material has high export demand and considerable profit margins.<\/p>\n\n\n\n<h2 id=\"10-benzoyl-peroxide-a-safe-bet-in-dermatological-apis\" class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"10_Benzoyl_Peroxide_%E2%80%93_A_Safe_Bet_in_Dermatological_APIs\"><\/span><strong>10. Benzoyl Peroxide \u2013 A Safe Bet in Dermatological APIs<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Benzoyl Peroxide is still topical used all over the world for treating acne and other mild dermatological conditions. While the prepared dosage forms have tight controls, the compliance burden for the intermediate is somewhat lower.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Its manufacture involves the reaction of benzoyl chloride with hydrogen peroxide under basic conditions. The US and EU markets for skincare products are huge, and this simpler process enables MSMEs meeting export demand without significant capital investments.<\/p>\n\n\n\n<h2 id=\"what-are-the-considerations-for-msmes-manufacturing\" class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"What_Are_the_Considerations_for_MSMEs_Manufacturing\"><\/span><strong>What Are the Considerations for MSMEs Manufacturing?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">The manufacture of pharmaceutical intermediates typically entails the synthesis, purification, and crystallization in reactors. Since there is no need for rigorous final testing and clinical validation for the end product, these processes are less complex than full API manufacturing. Modular plants comprising jacketed vessels, rotary evaporators, and temperature controlled drying units can be used by MSMEs.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">While contract QC labs and third-party certifying agencies can streamline many processes for Export-Ready facilities, there are still critical factors such as packaging, MSDS documentation, and REACH registrations for EU-bound shipments that still need to be handled in-house. Additionally, quality assurance is also critical, and the levels of pharmacopeial standards cited need to be compliant with the purity, moisture content and impurity profile.<\/p>\n\n\n\n<h2 id=\"reasons-why-pharmaceutical-intermediates-are-best-for-msmes\" class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Reasons_Why_Pharmaceutical_Intermediates_Are_Best_for_MSMEs\"><\/span><strong>Reasons Why Pharmaceutical Intermediates Are Best for MSMEs<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Pharmaceutical intermediates are situated precisely in the sweet spot:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Regulations are less stringent than for APIs or formulations.<br><\/li>\n\n\n\n<li>Pharmaceutical intermediates have greater overseas demand than generic chemicals.<br><\/li>\n\n\n\n<li>They allow entry into the pharma value chain without heavy clinical spending.<br><\/li>\n\n\n\n<li>Capability to cater to pharma and allied sectors.<br><\/li>\n\n\n\n<li>Opportunities for innovation in process chemistry and reduction of impurities.<br><\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">These reasons make the category very appealing for Indian MSMEs that seek to position themselves as global suppliers.<\/p>\n\n\n\n<h3 id=\"for-more-information-check-our-project-reports\" class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"For_more_information_check_our_Project_Reports\"><\/span><a href=\"https:\/\/www.niir.org\/profile-projects-reports\/profiles\/active-pharmaceutical-ingredient-api-products-bulk-api-manufacturing\/z,,e6,0,a\/index.html\">For more information check our Project Reports<\/a><span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<h2 id=\"how-npcs-assists-with-your-pharma-intermediate-manufacturing-needs\" class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"How_NPCS_Assists_With_Your_Pharma_Intermediate_Manufacturing_Needs\"><\/span><strong>How NPCS Assists With Your Pharma Intermediate Manufacturing Needs<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">NIIR Project Consultancy Services (NPCS) specializes in assisting entrepreneurs and industrialists to set up intermediate pharmaceutical manufacturers agnostically, as MSMEs.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">They specialize in working with regional entrepreneurs for creating Market Survey cum Detailed Techno Economic Feasibility Reports, which strategically help MSMEs identify crucial demand drivers and assess operational profitability.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">NPCS considers all aspects of materials, equipment, and processes in manufacturing automation as well as stringent quality control of final products.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">NPCS aids in sound investment-disburnsement allocation for segment targeted thorough detailed feasibility analysis and assisted decision-making.<\/p>\n\n\n\n<h2 id=\"conclusion-a-local-edge-in-a-global-market\" class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Conclusion_A_Local_Edge_in_a_Global_Market\"><\/span><strong>Conclusion: A Local Edge in a Global Market<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">India possesses both the infrastructure and intellect to spearhead in exporting pharmaceutical intermediates with the change in global demand and rising regulatory standards. For startups and MSMEs, the route is straightforward\u2014choose suitable intermediates, construct modular and compliant plants, and support the global value chain with precision, efficiency, and unwavering consistency.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">As India\u2019s small manufacturers position themselves within the shifting global pharmaceutical supply chain, they have the opportunity to transform from being mere suppliers to becoming key strategic partners. Backed by NPCS\u2019s expert guidance, your entry into this high-growth sector can be streamlined for efficiency, sustainability, and profitability.<\/p>\n\n\n\n<h3 id=\"which-business-to-start-how-to-choose-a-business-idea\" class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Which_business_to_start_How_to_choose_a_business_idea\"><\/span><a href=\"https:\/\/www.entrepreneurindia.co\/business-finder\">Which business to start? How to choose a business idea?<\/a><span class=\"ez-toc-section-end\"><\/span><\/h3>\n","protected":false},"excerpt":{"rendered":"A Sunrise Opportunity for MSMEs in Pharmaceutical Intermediates Manufacturing India is known internationally for its generic drug production.&hellip;","protected":false},"author":24,"featured_media":21110,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"iawp_total_views":310,"csco_display_header_overlay":false,"csco_singular_sidebar":"","csco_page_header_type":"","footnotes":""},"categories":[16847],"tags":[16174,16173],"industry":[],"class_list":["post-21109","post","type-post","status-publish","format-standard","has-post-thumbnail","category-pharmaceutical-industry","tag-export-2","tag-pharmaceutical-2","cs-entry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Top 10 Pharmaceutical Intermediates with High Export Potential for MSMEs<\/title>\n<meta name=\"description\" content=\"Unlike the other domains, pharmaceutical intermediates have lower regulation, require lower capital as well as investment\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.niir.org\/blog\/top-10-pharmaceutical-intermediates\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Top 10 Pharmaceutical Intermediates with High Export Potential for MSMEs\" \/>\n<meta property=\"og:description\" content=\"Unlike the other domains, pharmaceutical intermediates have lower regulation, require lower capital as well as investment\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.niir.org\/blog\/top-10-pharmaceutical-intermediates\/\" \/>\n<meta property=\"og:site_name\" content=\"Niir Project Consultancy Services\" \/>\n<meta property=\"article:published_time\" content=\"2025-07-07T11:51:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-05-15T06:41:42+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.niir.org\/blog\/wp-content\/uploads\/2025\/07\/top-10-pharmaceutical-intermediates-with-high-expo.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1820\" \/>\n\t<meta property=\"og:image:height\" content=\"1024\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"P.K. Chattopadhyay\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"P.K. Chattopadhyay\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"7 minutes\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Top 10 Pharmaceutical Intermediates with High Export Potential for MSMEs","description":"Unlike the other domains, pharmaceutical intermediates have lower regulation, require lower capital as well as investment","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.niir.org\/blog\/top-10-pharmaceutical-intermediates\/","og_locale":"en_US","og_type":"article","og_title":"Top 10 Pharmaceutical Intermediates with High Export Potential for MSMEs","og_description":"Unlike the other domains, pharmaceutical intermediates have lower regulation, require lower capital as well as investment","og_url":"https:\/\/www.niir.org\/blog\/top-10-pharmaceutical-intermediates\/","og_site_name":"Niir Project Consultancy Services","article_published_time":"2025-07-07T11:51:00+00:00","article_modified_time":"2026-05-15T06:41:42+00:00","og_image":[{"width":1820,"height":1024,"url":"https:\/\/www.niir.org\/blog\/wp-content\/uploads\/2025\/07\/top-10-pharmaceutical-intermediates-with-high-expo.webp","type":"image\/webp"}],"author":"P.K. Chattopadhyay","twitter_card":"summary_large_image","twitter_misc":{"Written by":"P.K. Chattopadhyay","Est. reading time":"7 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.niir.org\/blog\/top-10-pharmaceutical-intermediates\/#article","isPartOf":{"@id":"https:\/\/www.niir.org\/blog\/top-10-pharmaceutical-intermediates\/"},"author":{"name":"P.K. Chattopadhyay","@id":"\/#\/schema\/person\/032fbcdb9414ea966c10a362ae2b739a"},"headline":"Top 10 Pharmaceutical Intermediates with High Export Potential for MSMEs","datePublished":"2025-07-07T11:51:00+00:00","dateModified":"2026-05-15T06:41:42+00:00","mainEntityOfPage":{"@id":"https:\/\/www.niir.org\/blog\/top-10-pharmaceutical-intermediates\/"},"wordCount":1429,"image":{"@id":"https:\/\/www.niir.org\/blog\/top-10-pharmaceutical-intermediates\/#primaryimage"},"thumbnailUrl":"https:\/\/www.niir.org\/blog\/wp-content\/uploads\/2025\/07\/top-10-pharmaceutical-intermediates-with-high-expo.webp","keywords":["Export","Pharmaceutical"],"articleSection":["Pharmaceutical Business Ideas"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.niir.org\/blog\/top-10-pharmaceutical-intermediates\/","url":"https:\/\/www.niir.org\/blog\/top-10-pharmaceutical-intermediates\/","name":"Top 10 Pharmaceutical Intermediates with High Export Potential for MSMEs","isPartOf":{"@id":"\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.niir.org\/blog\/top-10-pharmaceutical-intermediates\/#primaryimage"},"image":{"@id":"https:\/\/www.niir.org\/blog\/top-10-pharmaceutical-intermediates\/#primaryimage"},"thumbnailUrl":"https:\/\/www.niir.org\/blog\/wp-content\/uploads\/2025\/07\/top-10-pharmaceutical-intermediates-with-high-expo.webp","datePublished":"2025-07-07T11:51:00+00:00","dateModified":"2026-05-15T06:41:42+00:00","author":{"@id":"\/#\/schema\/person\/032fbcdb9414ea966c10a362ae2b739a"},"description":"Unlike the other domains, pharmaceutical intermediates have lower regulation, require lower capital as well as investment","inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.niir.org\/blog\/top-10-pharmaceutical-intermediates\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.niir.org\/blog\/top-10-pharmaceutical-intermediates\/#primaryimage","url":"https:\/\/www.niir.org\/blog\/wp-content\/uploads\/2025\/07\/top-10-pharmaceutical-intermediates-with-high-expo.webp","contentUrl":"https:\/\/www.niir.org\/blog\/wp-content\/uploads\/2025\/07\/top-10-pharmaceutical-intermediates-with-high-expo.webp","width":1820,"height":1024,"caption":"Pharmaceutical Intermediates"},{"@type":"WebSite","@id":"\/#website","url":"\/","name":"Niir Project Consultancy Services","description":"Project Reports, Business Plan","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"\/#\/schema\/person\/032fbcdb9414ea966c10a362ae2b739a","name":"P.K. Chattopadhyay","pronouns":"he\/him","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.niir.org\/blog\/wp-content\/litespeed\/avatar\/3662e7afd36f344fe355fb0ede1d751d.jpg?ver=1788612902","url":"https:\/\/www.niir.org\/blog\/wp-content\/litespeed\/avatar\/3662e7afd36f344fe355fb0ede1d751d.jpg?ver=1788612902","contentUrl":"https:\/\/www.niir.org\/blog\/wp-content\/litespeed\/avatar\/3662e7afd36f344fe355fb0ede1d751d.jpg?ver=1788612902","caption":"P.K. Chattopadhyay"},"description":"P. K. Chattopadhyay is a seasoned Project Consultant with over 45 years of hands-on experience in project consultancy across diverse industries. He has guided hundreds of companies and entrepreneurs through project planning, feasibility studies, and industrial setup \u2014 turning business ideas into practical, scalable ventures. A prolific author of business and startup-focused books, P. K. Chattopadhyay brings together real-world industry data, actionable insights, and proven execution strategies tailored for entrepreneurs and investors at every stage of their journey. His core expertise spans manufacturing projects, market analysis, and business viability assessment \u2014 making his work an indispensable resource for anyone building a sustainable and profitable business from the ground up.","sameAs":["https:\/\/www.linkedin.com\/in\/p-k-chattopadhyay-466751406\/"],"url":"https:\/\/www.niir.org\/blog\/author\/p-k-chattopadhyay\/"}]}},"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.niir.org\/blog\/wp-json\/wp\/v2\/posts\/21109","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.niir.org\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.niir.org\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.niir.org\/blog\/wp-json\/wp\/v2\/users\/24"}],"replies":[{"embeddable":true,"href":"https:\/\/www.niir.org\/blog\/wp-json\/wp\/v2\/comments?post=21109"}],"version-history":[{"count":1,"href":"https:\/\/www.niir.org\/blog\/wp-json\/wp\/v2\/posts\/21109\/revisions"}],"predecessor-version":[{"id":21111,"href":"https:\/\/www.niir.org\/blog\/wp-json\/wp\/v2\/posts\/21109\/revisions\/21111"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.niir.org\/blog\/wp-json\/wp\/v2\/media\/21110"}],"wp:attachment":[{"href":"https:\/\/www.niir.org\/blog\/wp-json\/wp\/v2\/media?parent=21109"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.niir.org\/blog\/wp-json\/wp\/v2\/categories?post=21109"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.niir.org\/blog\/wp-json\/wp\/v2\/tags?post=21109"},{"taxonomy":"industry","embeddable":true,"href":"https:\/\/www.niir.org\/blog\/wp-json\/wp\/v2\/industry?post=21109"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}